The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Vectura Delivers "Good" 2017 Results Despite Advair Disappointment

Wed, 21st Mar 2018 08:52

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC said Wednesday it delivered a "good" set of 2017 results with underlying profit and revenue growth despite "disappointing" delays to its generic competitor to GlaxoSmithKline PLC's blockbuster Advair drug.

For the twelve months of 2017, pretax loss was reported at GBP102.2 million. This was compared to GBP40.1 million for the nine-months ended December 2016. No pro forma full year pretax profit figures were provided.

On an adjusted, underlying earnings before interest, tax, depreciation and amortisation basis - which excludes exceptional items - it swung to a profit of GBP10.0 million for the twelve months of 2017 compared to a pro forma GBP2.6 million loss for the twelve months of 2016.

In July 2016, Vectura changed its financial year end from March 31 to December 31 shortly after completion of its all-share GBP441.3 million acquisition of Skyepharma PLC.

Underlying revenue for 2017 rose to GBP131.4 million from pro forma GBP126.3 million in 2016.

Vectura does not pay a dividend.

"It has been an important year of progress for Vectura," Chief Executive Officer James Ward-Lilley said. "We have delivered a good set of financial results, in line with market expectations, and our key partnered inhaled products, flutiform and Ultibro Breezhaler, have continued to show strong in-market growth."

"Notwithstanding the disappointing delays we have seen for our VR315 (US) generic Advair programme, we continue to see substantial value in the development of complex inhaled generics," Ward-Lilley added. "In light of this, we have extended our valuable inhaled generics portfolio. In addition, we have also progressed our enhanced therapy pipeline and fully delivered our merger integration plans."

"Our refocused investment strategy, announced in January 2018, is underpinned by a strong core business, tight financial discipline and a skilled workforce," Ward-Lilley added. "We are committed to fully leveraging the capabilities and technologies that differentiate us to maximise the value of our pipeline at a substantially lower cost and relative risk. We have clearly defined priorities and we look forward to a series of significant news flow catalysts during 2018."

Shares in Vectura were 2.3% lower at 78.80 pence on Wednesday.

More News
10 Aug 2021 09:16

Philip Morris switches Vectura scheme of arrangement to takeover offer

(Sharecast News) - Philip Morris has switched its bid for London-listed inhaler maker Vectura to a takeover offer from a scheme of arrangement, which means the US tobacco giant will now require a lower level of shareholder approval.

Read more
10 Aug 2021 07:48

LONDON MARKET PRE-OPEN: Jackpot first half for Flutter Entertainment

LONDON MARKET PRE-OPEN: Jackpot first half for Flutter Entertainment

Read more
9 Aug 2021 16:57

LONDON MARKET CLOSE: FTSE squeezes gains but traders eye virus worries

LONDON MARKET CLOSE: FTSE squeezes gains but traders eye virus worries

Read more
9 Aug 2021 12:05

LONDON MARKET MIDDAY: Stocks fall on US Fed support withdrawal fears

LONDON MARKET MIDDAY: Stocks fall on US Fed support withdrawal fears

Read more
9 Aug 2021 12:03

LIVE MARKETS-Mini-bubbles: little to worry about

* European shares little changed* Deliveroo jumps as rival takes stake* S&P 500 futures dipAug 9 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@th...

Read more
9 Aug 2021 10:21

LIVE MARKETS-Taking stock of Europe's record season

* European shares little changed* Deliveroo jumps as rival takes stake* S&P 500 futures dipAug 9 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@th...

Read more
9 Aug 2021 10:18

TOP NEWS: Auction set as Philip Morris and Carlyle battle for Vectura

TOP NEWS: Auction set as Philip Morris and Carlyle battle for Vectura

Read more
9 Aug 2021 10:15

UPDATE 2-Philip Morris, Carlyle could fight it out for UK's Vectura in auction ring

* Deadline for final bids is 5 p.m. BST/1600 GMT Aug. 10* Auctions to begin Aug. 11, Wednesday* Vectura withdraws support for Carlyle's increased offer* Philip Morris on Sunday offered 165 pence per share for Vectura (Adds details, background)By P...

Read more
9 Aug 2021 09:55

UPDATE 2-FTSE 100 closes higher but held back by energy sector losses

* Deliveroo surges after German peer buys stake* Hargreaves Lansdown slumps on profit miss* Weak gold and metal prices drag miners* Miners reverse early losses (Updates to market close)By Shashank Nayar and Ambar WarrickAug 9 (Reuters) - Steep losse...

Read more
9 Aug 2021 09:42

UPDATE 2-Defensive, technology stocks power European markets to record close

* Healthcare, utilities, tech top sectoral gainers* Deliveroo jumps on Delivery Hero stake buy* HeidelbergCement slides on Barclays downgrade (Adds comments, updates prices throughout)By Shreyashi SanyalAug 9 (Reuters) - European stocks reached a re...

Read more
9 Aug 2021 08:56

LIVE MARKETS-Mixed feelings in Europe

Aug 9 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comMIXED FEELINGS IN EUROPE (0754 GMT)A fall in oil and gold prices is pushing...

Read more
9 Aug 2021 08:49

LONDON MARKET OPEN: Hargreaves Lansdown falls on higher costs warning

LONDON MARKET OPEN: Hargreaves Lansdown falls on higher costs warning

Read more
9 Aug 2021 08:44

Battle for Vectura could go to auction as Philip Morris lifts bid

(Sharecast News) - Vecura has withdrawn its intention to recommend the sweetened offer made by Carlyle at the end of last week after an increased offer from Philip Morris, as the UK Takeover Panel said the process would be put to auction if both suitors don't make final bids by Tuesday.

Read more
9 Aug 2021 08:33

LIVE MARKETS-Pestilence and wildfires

Aug 9 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comPESTILENCE AND WILDFIRES (0730 GMT)Chinese imports and exports both undersh...

Read more
9 Aug 2021 08:06

MORNING BID-Pestilence and wildfires

A look at the day ahead from Sujata Rao.Chinese imports and exports both undershot expectations last month, data showed on the weekend, impacted in part by the COVID-19 resurgence across the country and the rest of Asia. Those outbreaks have also ...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.